Beijing Inno Medicine Co., Ltd.
Clinical trials sponsored by Beijing Inno Medicine Co., Ltd., explained in plain language.
-
New drug trial targets dual threat: heart disease and ED
Disease control Not yet recruitingThis study is testing an investigational drug called YN001 in men who have both atherosclerotic heart disease and erectile dysfunction. The goal is to see if YN001 can improve blood vessel health and sexual function over 13 weeks. About 40 participants will be randomly assigned t…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
First test: can new heart drug safely mix with standard meds?
Disease control Not yet recruitingThis early-stage study aims to check if a new experimental drug called YN001 is safe to take alongside a widely used cholesterol medication, rosuvastatin. It will involve 24 healthy Chinese volunteers to see how the two drugs interact in the body and monitor for any side effects.…
Phase: PHASE1 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC